Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,988 GBX | +5.60% | +10.06% | +13.32% |
03:40pm | ASTRAZENECA : UBS maintains a Sell rating | ZD |
03:22pm | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
Financials (USD)
Sales 2024 * | 50.8B | Sales 2025 * | 54.49B | Capitalization | 219B |
---|---|---|---|---|---|
Net income 2024 * | 8.7B | Net income 2025 * | 10.26B | EV / Sales 2024 * | 4.7 x |
Net Debt 2024 * | 19.83B | Net Debt 2025 * | 12.92B | EV / Sales 2025 * | 4.25 x |
P/E ratio 2024 * |
25.8
x | P/E ratio 2025 * |
21.7
x | Employees | 89,900 |
Yield 2024 * |
2.19% | Yield 2025 * |
2.31% | Free-Float | 96.5% |
Latest transcript on AstraZeneca PLC
1 day | +5.94% | ||
1 week | +10.41% | ||
Current month | +12.85% | ||
1 month | +15.93% | ||
3 months | +15.33% | ||
6 months | +14.26% | ||
Current year | +13.68% |
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 63 | 12-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 21-07-31 |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 17-09-30 |
Ahmed Hamdy
PRN | Corporate Officer/Principal | 59 | 13-01-31 |
Philip Broadley
BRD | Director/Board Member | 63 | 17-04-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.20% | 11 M€ | +0.83% | - | |
5.39% | 192 M€ | +11.68% | ||
5.17% | 18 M€ | +3.04% | - | |
4.89% | 776 M€ | +7.27% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 12,010 | +5.80% | 1 810 818 |
24-04-24 | 11,352 | +0.75% | 3,596,131 |
24-04-23 | 11,268 | +0.16% | 3,561,073 |
24-04-22 | 11,250 | +2.78% | 3,448,159 |
24-04-19 | 10,946 | +0.29% | 1,407,714 |
Delayed Quote London S.E., April 25, 2024 at 09:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.68% | 219B | |
+23.88% | 562B | |
-5.99% | 358B | |
+20.90% | 322B | |
+8.30% | 297B | |
+6.43% | 199B | |
-10.27% | 196B | |
-9.67% | 149B | |
-5.73% | 146B | |
+2.24% | 117B |
- Stock Market
- Equities
- AZN Stock